|
BFTP alumnus client OraSure Technologies, Inc. (NASDAQ:OSUR), Bethlehem, a leader in point-of-care diagnostic tests and specimen collection devices, announced the sale of its cryosurgical systems business to CryoConcepts, LP, Bethlehem, for $12 million. “Our plan is to leverage the Histofreezer® brand to accelerate our introduction of a new generation of cryosurgical products to the professional and consumer markets on a global basis. This acquisition also keeps and creates jobs in the Lehigh Valley,” said Sam Niedbala, Ph.D., CEO of CryoConcepts, LP. Read more.
|